Patient beliefs about chemotherapy, cancer influence care choices at the end of life
the ONA take:
In an assessment of the impact of patients’ beliefs on their choices for care at the end of life, researchers found that patients with advanced cancer who believed chemotherapy might cure their cancer were more likely to receive chemotherapy in the last month of life and less likely to enroll in hospice care before death.
The study examined 722 patients with stage IV lung or colorectal cancer who completed a baseline survey and died during the study period.
The association of understanding goals for chemotherapy with its use in the last month of life and hospice enrollment before death was assessed using logistic regression. One-third of the patients understood that chemotherapy was “not at all” likely to cure their cancer.
However, use of chemotherapy among these patients was similar to that of other patients at end of life.
The study concludes that patients with advanced cancer who were well informed about chemotherapy's goals received late-life chemotherapy at rates similar to those for other patients. However, understanding the incurable nature of cancer is associated with increased hospice enrollment before death.
Patients with advanced cancer who believed chemotherapy might cure their cancer were more likely to receive chemotherapy.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- PPIs Negatively Impact Outcomes of Patients Treated With Capecitabine
- How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- Pseudohyperkalemia: False Potassium Levels Occur in a Patient With Lymphoma
- Atezolizumab Granted FDA Approval for Specific Cases of NSCLC
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- High U.S. Economic Burden for Vaccine-Preventable Diseases
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|